B7-H4 was mainly expressed on the membrane and in the cytoplasm of tumor cells, while normal urothelium and tumor-infiltrating lymphocytes showed no or very weak reactivity for anti-B7-H4 antibody (Fig. 1). Here, VTCN1 is linked to neoplasm.